{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:09:07Z","timestamp":1787497747822,"version":"build-2736575974"},"reference-count":115,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T00:00:00Z","timestamp":1284595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The role of mechanistic modeling and systems biology in molecular medicine remains unclear. In this study, we explored whether uncertain models could be used to understand how a network responds to a therapeutic intervention. As a proof of concept, we modeled and analyzed the response of the human coagulation cascade to recombinant factor VIIa (rFVIIa) and prothrombin (fII) addition in normal and hemophilic plasma. An ensemble of parametrically uncertain human coagulation models was developed (N = 437). Each model described the time evolution of 193 proteins and protein complexes interconnected by 301 interactions under quiescent flow. The 467 unknown model parameters were estimated, using multiobjective optimization, from published in vitrocoagulation studies. The model ensemble was validated using published in vitro thrombin measurements and thrombin measurements taken from coronary artery disease patients. Sensitivity analysis was then used to rank-order the importance of model parameters as a function of experimental or physiological conditions. A novel strategy for the systematic comparison of ranks identified a family of fX\/FXa and fII\/FIIa interactions that became more sensitive with decreasing fVIII\/fIX. The fragility of these interactions was preserved following the addition of exogenous rFVIIa and fII. This suggested that exogenous rFVIIa did not alter the qualitative operation of the cascade. Rather, exogenous rFVIIa and fII took advantage of existing fluid and interfacial fX\/FXa and fII\/FIIa sensitivity to restore normal coagulation in low fVIII\/fIX conditions. The proposed rFVIIa mechanism of action was consistent with experimental literature not used in model training. Thus, we demonstrated that an ensemble of uncertain models could unravel key facets of the mechanism of action of a focused intervention. Whereas the current study was limited to coagulation, perhaps the general strategy used could be extended to other molecular networks relevant to human health.<\/jats:p>\n                  <jats:p\/>","DOI":"10.1039\/b920693k","type":"journal-article","created":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T06:42:23Z","timestamp":1284619343000},"page":"2272-2286","source":"Crossref","is-referenced-by-count":27,"title":["Ensembles of uncertain mathematical models can identify network response to therapeutic interventions"],"prefix":"10.1093","volume":"6","author":[{"given":"Deyan","family":"Luan","sequence":"first","affiliation":[{"name":"School of Chemical and Biomolecular Engineering, Cornell University a , 244 Olin Hall, Ithaca NY 14853 USA \u00a0 jdv27@cornell.edu \u00a0 (+1 607) 255-9166 \u00a0 (+1 607) 255-4258"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fania","family":"Szlam","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Emory University School of Medicine c , Atlanta GA 30322, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi A","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Emory University School of Medicine c , Atlanta GA 30322, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S","family":"Barie","sequence":"additional","affiliation":[{"name":"Departments of Surgery and Public Health, Weill Cornell Medical College b , New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D","family":"Varner","sequence":"additional","affiliation":[{"name":"School of Chemical and Biomolecular Engineering, Cornell University a , 244 Olin Hall, Ithaca NY 14853 USA \u00a0 jdv27@cornell.edu \u00a0 (+1 607) 255-9166 \u00a0 (+1 607) 255-4258"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,9,16]]},"reference":[{"key":"2026012913201690300_cit1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nature01254","article-title":"Computational systems biology","volume":"420","author":"Kitano","year":"2002","journal-title":"Nature"},{"key":"2026012913201690300_cit2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1586\/14737159.6.6.891","article-title":"Dynamics of biological systems: role of systems biology in medical research","volume":"6","author":"Assmus","year":"2006","journal-title":"Expert Rev. Mol. Diagn."},{"key":"2026012913201690300_cit3","first-page":"17","article-title":"Systems biology's clinical future","volume":"84","author":"Arnaud","year":"2006","journal-title":"Chem. Eng. News"},{"key":"2026012913201690300_cit4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/89204","article-title":"Complex biology with no parameters","volume":"19","author":"Bailey","year":"2001","journal-title":"Nat. Biotechnol."},{"issue":"Suppl 1","key":"2026012913201690300_cit5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1538-7836.2009.03463.x","article-title":"Systems biology to predict blood function","volume":"7","author":"Diamond","year":"2009","journal-title":"J. Thromb. Haemostasis"},{"key":"2026012913201690300_cit6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2516.1998.440331.x","article-title":"Newer concepts of blood coagulation","volume":"4","author":"Roberts","year":"1998","journal-title":"Haemophilia"},{"key":"2026012913201690300_cit7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-0037-1615780","article-title":"Biochemistry and physiology of blood coagulation","volume":"82","author":"Mann","year":"1999","journal-title":"Thromb. Haemostasis"},{"key":"2026012913201690300_cit8","first-page":"5","article-title":"Blood coagulation","volume":"67","author":"Butenas","year":"2002","journal-title":"Biochemistry"},{"key":"2026012913201690300_cit9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.moh.0000130308.37353.d4","article-title":"The blood coagulation cascade","volume":"11","author":"Schenone","year":"2004","journal-title":"Curr. Opin. Hematol."},{"key":"2026012913201690300_cit10","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1073\/pnas.96.5.2311","article-title":"et al., Blood-borne tissue factor: another view of thrombosis","volume":"96","author":"Giesen","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026012913201690300_cit11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V76.1.1.1","article-title":"Surface-dependent reactions of vitamin K-dependent enzyme complexes","volume":"76","author":"Mann","year":"1990","journal-title":"Blood"},{"key":"2026012913201690300_cit12","volume-title":"Hemostasis and Thrombosis: Basic Principles and Clinical Practice","author":"Goldhaber","year":"2006"},{"key":"2026012913201690300_cit13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood.V100.1.148","article-title":"Thrombin functions during tissue factor-induced blood coagulation","volume":"100","author":"Brummel","year":"2002","journal-title":"Blood"},{"key":"2026012913201690300_cit14","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1182\/blood.V99.3.923","article-title":"Mechanism of factor VIIa-dependent coagulation in hemophilia blood","volume":"99","author":"Butenas","year":"2002","journal-title":"Blood"},{"key":"2026012913201690300_cit15","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"2026012913201690300_cit16","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1213\/ane.0b013e31819bcc9c","article-title":"Blood coagulation: hemostasis and thrombin regulation","volume":"108","author":"Tanaka","year":"2009","journal-title":"Anesth. Analg. (N.Y.)"},{"key":"2026012913201690300_cit17","volume-title":"The molecular genetics of haemostasis and its inherited disorders","author":"Tuddenham","year":"1994"},{"key":"2026012913201690300_cit18","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJM200106073442307","article-title":"The hemophilias\u2014from royal genes to gene therapy","volume":"344","author":"Mannucci","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"2026012913201690300_cit19","first-page":"26","article-title":"Haemophilia and inhibitors 1: diagnosis and treatment","volume":"104","author":"Mitchell","year":"2008","journal-title":"Nursing Times"},{"key":"2026012913201690300_cit20","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.0042-9007.2003.00365.x","article-title":"et al., A novel therapeutic approach combining human plasma-derived factors viia and x for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with factor viia alone","volume":"85","author":"Tomokiyo","year":"2003","journal-title":"Vox Sang."},{"key":"2026012913201690300_cit21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0002-9343(88)80353-X","article-title":"Acute mycardial infarction during treatment with an activated prothrombin complex concentrate in a patient with factor viii deficiency and a factor viii inhibitor","volume":"85","author":"Chavin","year":"1988","journal-title":"Am. J. Med."},{"key":"2026012913201690300_cit22","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2141.2006.06178.x","article-title":"Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia","volume":"134","author":"Allen","year":"2006","journal-title":"Br. J. Haematol."},{"key":"2026012913201690300_cit23","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2516.2007.01451.x","article-title":"Sequential therapy with activated prothrombin complex concentrates and recombinant FVIIa in patients with severe haemophilia and inhibitors: update of our previous experience","volume":"13","author":"Schneiderman","year":"2007","journal-title":"Haemophilia"},{"key":"2026012913201690300_cit24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1160\/TH08-07-0434","article-title":"Factor viia and its potential therapeutic use in bleeding-associated pathologies","volume":"100","author":"Hedner","year":"2008","journal-title":"Thromb. Haemostasis"},{"key":"2026012913201690300_cit25","doi-asserted-by":"crossref","first-page":"477","DOI":"10.5435\/00124635-200908000-00001","article-title":"The use of recombinant factor viia in trauma patients","volume":"17","author":"Talbot","year":"2009","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"2026012913201690300_cit26","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1046\/j.1365-2516.1998.00209.x","article-title":"et al., A randomized, double-blind comparison of two dosage levels of recombinant factor viia in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia a and b, with and without inhibitors. rfviia study group","volume":"4","author":"Lusher","year":"1998","journal-title":"Haemophilia"},{"key":"2026012913201690300_cit27","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1055\/s-0037-1615357","article-title":"Prospective, randomised trial of two doses of rfviia (novoseven) in haemophilia patients with inhibitors undergoing surgery","volume":"80","author":"Shapiro","year":"1998","journal-title":"Thromb. Haemostasis"},{"key":"2026012913201690300_cit28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-2000-8461","article-title":"Recombinant factor viia in the treatment of bleeding in hemophilic children with inhibitors","volume":"26","author":"Shapiro","year":"2000","journal-title":"Semin. Thromb. Hemostasis"},{"key":"2026012913201690300_cit29","first-page":"579","article-title":"Single-dose recombinant activated factor vii for the treatment of joint bleeds in hemophilia patients with inhibitors","volume":"6","author":"Shapiro","year":"2008","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"2026012913201690300_cit30","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1021\/bi00492a016","article-title":"Proteolytic activation of human factors ix and x by recombinant human factor viia: Effects of calcium, phospholipids and tissure factor","volume":"29","author":"Komiyama","year":"1990","journal-title":"Biochemistry"},{"key":"2026012913201690300_cit31","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1021\/bi9529770","article-title":"Effect of soluble tissue factor on the kinetic mechanism of factor viia: Enhancement of p-guanidinobenzoate substrate hydrolysis","volume":"35","author":"Payne","year":"1996","journal-title":"Biochemistry"},{"key":"2026012913201690300_cit32","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1365-2141.1997.4463256.x","article-title":"Platelet activity of high-dose factor viia is independent of tissure factor","volume":"99","author":"Monroe","year":"1997","journal-title":"Br. J. Haematol."},{"key":"2026012913201690300_cit33","first-page":"S61","article-title":"Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII","volume":"9","author":"Hoffman","year":"1998","journal-title":"Blood Coag. Fibrin."},{"key":"2026012913201690300_cit34","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1182\/blood-2004-06-2223","article-title":"The use of recombinant factor VIIa in the treatment of bleeding disorders","volume":"104","author":"Roberts","year":"2004","journal-title":"Blood"},{"key":"2026012913201690300_cit35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-2006-939552","article-title":"A cell-based model of thrombin generation","volume":"32","author":"Roberts","year":"2006","journal-title":"Semin. Thromb. Hemostasis"},{"key":"2026012913201690300_cit36","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1161\/01.ATV.0000257204.82396.2b","article-title":"et al., A variant of recombinant factor VIIa with enhanced procoagulant and antifibrinolytic activities in an in vitro model of hemophilia","volume":"27","author":"Allen","year":"2007","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"key":"2026012913201690300_cit37","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1177\/000313480807401206","article-title":"et al., urrent evidence based guidelines for factor viia use in trauma: the good, the bad, and the ugly","volume":"74","author":"Duchesne","year":"2008","journal-title":"Am. Surg."},{"key":"2026012913201690300_cit38","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1371\/journal.pcbi.0030142","article-title":"Computationally Derived Points of Fragility of a Human Cascade are Consistent with Current Therapeutic Strategies","volume":"3","author":"Luan","year":"2007","journal-title":"PLoS Comput. Biol."},{"key":"2026012913201690300_cit39","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1088\/1478-3967\/1\/3\/006","article-title":"et al., The statistical mechanics of complex signaling networks: nerve groth factor signaling","volume":"1","author":"Brown","year":"2004","journal-title":"Phys. Biol."},{"key":"2026012913201690300_cit40","first-page":"17","article-title":"Model identification of signal transduction networks from data using a state regulator problem","volume":"2","author":"Gadkar","year":"2005","journal-title":"IEE Proc.: Syst. Biol."},{"key":"2026012913201690300_cit41","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood.V94.7.2169.419k22_2169_2178","article-title":"\u2018Normal\u2019 thrombin generation","volume":"94","author":"Butenas","year":"1999","journal-title":"Blood"},{"key":"2026012913201690300_cit42","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1371\/journal.pcbi.0030189","article-title":"et al., Universally sloppy parameter sensitivities in systems biology models","volume":"3","author":"Gutenkunst","year":"2007","journal-title":"PLoS Comput. Biol."},{"key":"2026012913201690300_cit43","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1177\/0037549703040943","article-title":"Experimental Design in Systems Biology, Based on Parameter Sensitivity Analysis Using a Monte Carlo Method: A Case Study for the TNF\u03b1-Mediated NF-\u03b2-Signal Transduction Pathway","volume":"79","author":"Cho","year":"2003","journal-title":"Simulation"},{"key":"2026012913201690300_cit44","doi-asserted-by":"crossref","first-page":"13210","DOI":"10.1073\/pnas.0401463101","article-title":"Robustness properties of circadian clock architectures","volume":"101","author":"Stelling","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026012913201690300_cit45","first-page":"221","article-title":"Robustness properties of apoptosis models with respect to parameter variations and intrinsic noise","volume":"152","author":"Eissing","year":"2005","journal-title":"IEE Proc.: Syst. Biol."},{"key":"2026012913201690300_cit46","doi-asserted-by":"crossref","first-page":"e2016","DOI":"10.1371\/journal.pone.0002016","article-title":"Test of highly optimized tolerance reveals fragile cell-cycle mechanisms are molecular targets in clinical cancer trials","volume":"3","author":"Nayak","year":"2008","journal-title":"PLoS One"},{"key":"2026012913201690300_cit47","doi-asserted-by":"crossref","DOI":"10.1093\/imammb\/dqp011","article-title":"The impact of uncertainty in a blood coagulation model","author":"Danforth","year":"2009","journal-title":"Math. Med. Biol."},{"key":"2026012913201690300_cit48","first-page":"46","article-title":"Evolutionary design on a budget: robustness and optimality of bacteriophage T7","volume":"153","author":"You","year":"2006","journal-title":"IEE Proc.: Syst. Biol."},{"key":"2026012913201690300_cit49","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nrd2195","article-title":"A robustness based approach to systems-oriented drug design","volume":"6","author":"Kitano","year":"2007","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026012913201690300_cit50","doi-asserted-by":"crossref","first-page":"12841","DOI":"10.1073\/pnas.192442699","article-title":"et al., Untangling the wires: a strategy to trace functional interactions in signaling and gene networks","volume":"99","author":"Kholodenko","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026012913201690300_cit51","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1093\/bioinformatics\/bth173","article-title":"Inferring dynamic architecture of cellular networks using time series of gene expression, protein and metabolite data","volume":"20","author":"Sontag","year":"2004","journal-title":"Bioinformatics"},{"key":"2026012913201690300_cit52","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1101\/gr.1226004","article-title":"et al., A Benchmark for Methods in Reverse Engineering and Model Discrimination: Problem Formulation and Solutions","volume":"14","author":"Kremling","year":"2004","journal-title":"Genome Res."},{"key":"2026012913201690300_cit53","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1049\/iet-syb:20060065","article-title":"et al., Optimal experimental design in an EGFR signaling and down-regulation model","volume":"1","author":"Casey","year":"2007","journal-title":"IET Syst. Biol."},{"key":"2026012913201690300_cit54","doi-asserted-by":"crossref","DOI":"10.1007\/s11739-009-0293-9","article-title":"Oral factor xa inhibitors for thromboprophylaxis in major orthopedic surgery: a review","author":"Imberti","year":"2009","journal-title":"Intern. Emerg. Med."},{"issue":"Suppl 4","key":"2026012913201690300_cit55","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0049-3848(09)70144-6","article-title":"Novel anticoagulants and the future of anticoagulation","volume":"123","author":"Garcia","year":"2009","journal-title":"Thromb. Res."},{"key":"2026012913201690300_cit56","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1164368","article-title":"et al., Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","volume":"321","author":"Jones","year":"2008","journal-title":"Science"},{"key":"2026012913201690300_cit57","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1515\/CCLM.2009.140","article-title":"Pharmacogenetics of vitamin k antagonists: useful or hype?","volume":"47","author":"Lippi","year":"2009","journal-title":"Clin. Chem. Lab. Med."},{"key":"2026012913201690300_cit58","first-page":"183","article-title":"A Model Incorporating Some of the Mechanical and Biochemical Factors Underlying Clot Formation and Dissolution in Flowing Blood","volume":"5","author":"Anand","year":"2003","journal-title":"Journal of Theoretical Medicine"},{"key":"2026012913201690300_cit59","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000089931","article-title":"A model for the formation and lysis of blood clots","volume":"34","author":"Anand","year":"2005","journal-title":"Pathophysiol. Haemostasis Thromb."},{"key":"2026012913201690300_cit60","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1098\/rsif.2007.1202","article-title":"A multiscale model of thrombus development","volume":"5","author":"Xu","year":"2008","journal-title":"J. R. Soc. Interface"},{"key":"2026012913201690300_cit61","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/0953710031000092839","article-title":"Platelet activation in a circulating flow loop: combined effects of shear stress and exposure time","volume":"14","author":"Jesty","year":"2003","journal-title":"Platelets"},{"key":"2026012913201690300_cit62","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1016\/S0021-9258(20)89453-8","article-title":"Activation of human blood coagulation factor XI independent of factor XII","volume":"266","author":"Naito","year":"1991","journal-title":"J. Biol. Chem."},{"key":"2026012913201690300_cit63","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1073\/pnas.0507195103","article-title":"et al., Polyphosphate modulates blood coagulation and fibrinolysis","volume":"103","author":"Smith","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026012913201690300_cit64","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000073575","article-title":"The calibrated automated thrombogram (cat): a universal routine test for hyper- and hypocoagulability","volume":"32","author":"Hemker","year":"2002","journal-title":"Pathophysiol. Haemostasis Thromb."},{"key":"2026012913201690300_cit65","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1160\/TH08-06-0341","article-title":"In vitro evaluation of anti-factor IXa aptamer on thrombin generation, clotting time, and viscoelastometry","volume":"101","author":"Tanaka","year":"2009","journal-title":"Thromb. Haemostasis"},{"key":"2026012913201690300_cit66","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1126\/science.1064981","article-title":"Clotting factors build blood vessels","volume":"293","author":"Carmeliet","year":"2001","journal-title":"Science"},{"key":"2026012913201690300_cit67","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/35025229","article-title":"Thrombin signalling and protease-activated recpetors","volume":"407","author":"Coughlin","year":"2000","journal-title":"Nature"},{"key":"2026012913201690300_cit68","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1114\/1.200","article-title":"Computational simulation of platelet deposition and activation I. model development and properties","volume":"27","author":"Sorensen","year":"1999","journal-title":"Ann. Biomed. Eng."},{"key":"2026012913201690300_cit69","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.thromres.2004.10.013","article-title":"Historical perspective of factor XI","volume":"115","author":"Fujikawa","year":"2005","journal-title":"Thromb. Res."},{"key":"2026012913201690300_cit70","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1182\/blood.V68.1.225.225","article-title":"Functional characterization of platelet-bound factor XIa: Retention of factor XIa activity on the platelet surface","volume":"68","author":"Walsh","year":"1986","journal-title":"Blood"},{"key":"2026012913201690300_cit71","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1182\/blood.V86.8.3035.3035","article-title":"Feedback activation of factor xi by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis","volume":"86","author":"von dem Borne","year":"1995","journal-title":"Blood"},{"key":"2026012913201690300_cit72","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/01.ATV.0000128125.80559.9c","article-title":"Factor XI-dependent reciprocal thrombin generation consolidates blood coagulation when tissue factor is not available","volume":"24","author":"Wielders","year":"2004","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"key":"2026012913201690300_cit73","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0006-3495(01)76085-7","article-title":"Surface-mediated control of blood coagulation: The role of binding site densities and platelet deposition","volume":"80","author":"Kuharsky","year":"2001","journal-title":"Biophys. J."},{"key":"2026012913201690300_cit74","doi-asserted-by":"crossref","first-page":"23367","DOI":"10.1016\/S0021-9258(17)31662-9","article-title":"A model for the tissue factor pathway to thrombin: II a mathematical simulation","volume":"269","author":"Jones","year":"1994","journal-title":"J. Biol. Chem."},{"key":"2026012913201690300_cit75","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000089931","article-title":"A model for the formation and lysis of blood clots","volume":"34","author":"Anand","year":"2005","journal-title":"Pathophysiol. Haemostasis Thromb."},{"key":"2026012913201690300_cit76","first-page":"183","article-title":"A model incorporating some of the mechanical and biochemical factors underlying clot formation and dissolution in flowing blood","volume":"5","author":"Anand","year":"2003","journal-title":"Journal of Theoretical Medicine"},{"key":"2026012913201690300_cit77","doi-asserted-by":"crossref","first-page":"18322","DOI":"10.1074\/jbc.M201173200","article-title":"A model for the stoichiometric regulation of blood coagulation","volume":"277","author":"Hockin","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2026012913201690300_cit78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1162\/evco.2007.15.1.1","article-title":"Covariance matrix adaptation for multi-objective optimization","volume":"15","author":"Igel","year":"2007","journal-title":"Evol. Comput."},{"key":"2026012913201690300_cit79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1162\/evco.1995.3.1.1","article-title":"An Overview of Evolutionary Algorithms in Multiobjective Optimization","volume":"3","author":"Fonseca","year":"1995","journal-title":"Evol. Comput."},{"key":"2026012913201690300_cit80","doi-asserted-by":"crossref","first-page":"16904","DOI":"10.1073\/pnas.262658899","article-title":"An ensemble method for identifying regulatory circuits with special reference to the qa gene cluster of neurospora crassa","volume":"99","author":"Battogtokh","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026012913201690300_cit81","doi-asserted-by":"crossref","first-page":"11023","DOI":"10.1073\/pnas.96.20.11023","article-title":"How the protease thrombin talks to cells","volume":"96","author":"Coughlin","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026012913201690300_cit82","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1016\/S0021-9258(18)83649-3","article-title":"The roles of protein C and thrombomodulin in the regulation of blood coagulation","volume":"264","author":"Esmon","year":"1989","journal-title":"J. Biol. Chem."},{"key":"2026012913201690300_cit83","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1016\/S0021-9258(18)34877-4","article-title":"The interaction of human coagulation factor Va with platelets","volume":"257","author":"Kane","year":"1982","journal-title":"J. Biol. Chem."},{"key":"2026012913201690300_cit84","doi-asserted-by":"crossref","first-page":"20012","DOI":"10.1016\/S0021-9258(19)47211-6","article-title":"Platelet receptor occupancy with factor IXa promotes factor X activation","volume":"264","author":"Ahmad","year":"1989","journal-title":"J. Biol. Chem."},{"key":"2026012913201690300_cit85","doi-asserted-by":"crossref","first-page":"13071","DOI":"10.1074\/jbc.275.17.13071","article-title":"Structural and functional characterization of platelet receptor-mediated factor VIII binding","volume":"275","author":"Ahmad","year":"2000","journal-title":"J. Biol. Chem."},{"key":"2026012913201690300_cit86","doi-asserted-by":"crossref","first-page":"25383","DOI":"10.1074\/jbc.270.43.25383","article-title":"Mathematical model of serine protease inhibition in the tissue factor pathway to thrombin","volume":"270","author":"Leipold","year":"1995","journal-title":"J. Biol. Chem."},{"key":"2026012913201690300_cit87","doi-asserted-by":"crossref","first-page":"7983","DOI":"10.1074\/jbc.272.12.7983","article-title":"Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation","volume":"272","author":"Veer","year":"1997","journal-title":"J. Biol. Chem."},{"key":"2026012913201690300_cit88","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1182\/blood.V86.8.3035.3035","article-title":"Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis","volume":"86","author":"Kr von dem Borne","year":"1995","journal-title":"Blood"},{"key":"2026012913201690300_cit89","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1160\/TH05-01-0033","article-title":"Historical analysis of pai-1 from its discovery to its potential role in cell motility and disease","volume":"93","author":"Dellas","year":"2005","journal-title":"Thromb. Haemostasis"},{"key":"2026012913201690300_cit90","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1538-7836.2007.02816.x","article-title":"et al., Development of a new test for the global fibrinolytic capacity in whole blood","volume":"6","author":"Rijken","year":"2007","journal-title":"J. Thromb. Haemostasis"},{"key":"2026012913201690300_cit91","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0167-4838(94)90184-8","article-title":"et al., Plasminogen activator inhibitor type-i interascs exclusively with the proteinase domain of tissue plasminogen activator","volume":"1209","author":"Bjorquist","year":"1994","journal-title":"Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol."},{"key":"2026012913201690300_cit92","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1538-7836.2007.02422.x","article-title":"The regulation by fibrinogen and fibrin of tissue plasminogen activator kinetics and inhibition by plasminogen activator inhibitor 1","volume":"5","author":"Thelwell","year":"2007","journal-title":"J. Thromb. Haemostasis"},{"key":"2026012913201690300_cit93","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1432-1033.1988.tb14162.x","article-title":"Kinetics of inhibition of tissue-type and urokinase-type plassminogen activator by plasminogen-activator inhibitor type 1 and type 2","volume":"175","author":"Thorsen","year":"1988","journal-title":"Eur. J. Biochem."},{"key":"2026012913201690300_cit94","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0167-4838(82)90068-1","article-title":"Studies on the kinetics of plasminogen activation by tissure plasminogen activator","volume":"704","author":"Ranby","year":"1982","journal-title":"Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol."},{"key":"2026012913201690300_cit95","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1074\/jbc.270.13.7558","article-title":"Substrate specificity of tissure type plasminogen activator","volume":"270","author":"Madison","year":"1995","journal-title":"J. Biol. Chem."},{"key":"2026012913201690300_cit96","doi-asserted-by":"crossref","first-page":"12752","DOI":"10.1016\/S0021-9258(18)98963-5","article-title":"Plasminogen activation by receptor-bound urokinase","volume":"266","author":"Ellis","year":"1991","journal-title":"J. Biol. Chem."},{"key":"2026012913201690300_cit97","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1432-1033.1978.tb12200.x","article-title":"On the kinetics of the reaction between human antiplasmin and plasmin","volume":"84","author":"Wiman","year":"1978","journal-title":"Eur. J. Biochem."},{"key":"2026012913201690300_cit98","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1042\/bj3050097","article-title":"Reaction of human a2-antiplasmin and plasmin stopped-flow fluorescence kinetics","volume":"305","author":"Christensen","year":"1995","journal-title":"Biochem. J."},{"key":"2026012913201690300_cit99","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0049-3848(02)00020-8","article-title":"et al., Differences between neonates and adults in carbohydrate sequences and reaction kinetics of plasmin and a2-antiplasmin","volume":"105","author":"Ries","year":"2002","journal-title":"Thromb. Res."},{"key":"2026012913201690300_cit100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00001721-200302000-00014","article-title":"Influence of soluble fibrin on reaction kinetics of plasmin type 1 and type 2 with a2-antiplasmin","volume":"14","author":"Ries","year":"2003","journal-title":"Blood Coagulation Fibrinolysis"},{"key":"2026012913201690300_cit101","doi-asserted-by":"crossref","first-page":"17030","DOI":"10.1016\/S0021-9258(17)32515-2","article-title":"Regulation of fibrinolytic activity of neutrophil leukocyte elastase, plasmin, and miniplasmin by plasma protease inhibitors","volume":"269","author":"Kolev","year":"1994","journal-title":"J. Biol. Chem."},{"key":"2026012913201690300_cit102","doi-asserted-by":"crossref","first-page":"12329","DOI":"10.1016\/S0021-9258(18)98900-3","article-title":"Inhibition of cell surface receptor-bound plasmin by a2-antiplasmin and a2-macroglobulin","volume":"266","author":"Hall","year":"1991","journal-title":"J. Biol. Chem."},{"key":"2026012913201690300_cit103","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1128\/iai.61.12.5035-5043.1993","article-title":"et al., Alpha-2-macroglobulin fuctions as an inhibitor of fibrinolytic, clotting, and neutrophilic proteinases in sepsis: Studies using a baboon model","volume":"61","author":"De Boer","year":"1993","journal-title":"Infection and Immunity"},{"key":"2026012913201690300_cit104","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1074\/jbc.M313164200","article-title":"A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis","volume":"279","author":"Schneider","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2026012913201690300_cit105","doi-asserted-by":"crossref","first-page":"13340","DOI":"10.1074\/jbc.M313211200","article-title":"Activated thrombin-activatable fibrinolysis inhibitor reduces the ability of high molecular weight fibrin degradation procuctions to protect plasmin from antiplasmin","volume":"279","author":"Schneider","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2026012913201690300_cit106","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1046\/j.1538-7836.2003.00383.x","article-title":"Thrombus lysis by upa, scupa and tpa is regulated by plasma tafi","volume":"1","author":"Mutch","year":"2003","journal-title":"J. Thromb. Haemostasis"},{"key":"2026012913201690300_cit107","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1074\/jbc.273.4.2127","article-title":"Plasma and recombinant tafi and activated tafi compared with respect to glycosylation, thrombin\/thrombomodulindepent activation","volume":"273","author":"Boffa","year":"1998","journal-title":"J. Biol. Chem."},{"key":"2026012913201690300_cit108","doi-asserted-by":"crossref","first-page":"7091","DOI":"10.1073\/pnas.82.20.7091","article-title":"Discrimination between fibrin and fibrinogen by a monoclonal antibody against a synthetic peptide","volume":"82","author":"Scheefers-Borchel","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026012913201690300_cit109","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1016\/S0021-9258(18)42309-5","article-title":"et al., Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombinproteinase reactions. resolution of the antithrombin conformational change contribution to heparin rate enhancement","volume":"267","author":"Olson","year":"1992","journal-title":"J. Biol. Chem."},{"key":"2026012913201690300_cit110","first-page":"310","article-title":"Fondaparinux: The first pentasaccharide anticoagulant","volume":"27","author":"Ansani","year":"2002","journal-title":"PT"},{"key":"2026012913201690300_cit111","doi-asserted-by":"crossref","first-page":"14807","DOI":"10.1021\/bi00253a020","article-title":"Kinetic mechamism for the interaction of hirulog with thrombin","volume":"33","author":"Parry","year":"1994","journal-title":"Biochemistry"},{"key":"2026012913201690300_cit112","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1055\/s-0038-1657729","article-title":"The importance of enzyme inhibition kinetics for the effect of thrombin inhibitors in a rat model of arterial thrombosis","volume":"78","author":"Elg","year":"1997","journal-title":"Thromb Haemost"},{"key":"2026012913201690300_cit113","first-page":"1","article-title":"Effects of antithrombin and heparin cofactor II levels on anticoagulation with Intimatan","volume":"94","author":"Tanaka","year":"2005","journal-title":"Thromb. Haemostasis"},{"key":"2026012913201690300_cit114","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0021-9258(18)53998-3","article-title":"Complex-dependent inhibition of factor viia by antithrombin iii and heparin","volume":"268","author":"Lawson","year":"1993","journal-title":"J. Biol. Chem."},{"key":"2026012913201690300_cit115","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0049-3848(89)90069-8","article-title":"Purification and characterization of plasma protein c inhibitor","volume":"55","author":"Espana","year":"1989","journal-title":"Thromb. Res."}],"container-title":["Molecular BioSystems"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article-pdf\/6\/11\/2272\/66167831\/b920693k.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article-pdf\/6\/11\/2272\/66167831\/b920693k.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T18:30:14Z","timestamp":1769711414000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article\/6\/11\/2272\/8374299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,16]]},"references-count":115,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,9,16]]}},"URL":"https:\/\/doi.org\/10.1039\/b920693k","relation":{},"ISSN":["1742-2051","1742-206X"],"issn-type":[{"value":"1742-2051","type":"electronic"},{"value":"1742-206X","type":"print"}],"subject":[],"published-other":{"date-parts":[[2010,11,1]]},"published":{"date-parts":[[2010,9,16]]}}}